{"url_path":"/sec/ganx/8-k/2026-08-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1819411/0001104659-26-094041-index.html","accession_number":"0001104659-26-094041","cik":"0001819411","ticker":"GANX","issuer_name":"Gain Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1819411/0001104659-26-094041-index.html","primary_entity_key":"0001819411","primary_entity_name":"Gain Therapeutics, Inc."},"word_count":87,"has_tables":true,"body_markdown":"**Item 9.01 Financial Statements and Exhibits.**\n\n(d) Exhibits\n\n​\n\n99.1\n\n​\n\n[Press Release, dated August 11, 2026.](ganx-20260811xex99d1.htm)\n\n104\n\n​\n\nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n​\n\n​\n\n​\n\n​\n\n​\n\n**SIGNATURE**\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n**GAIN THERAPEUTICS, INC.**\n\nDate: August 11, 2026\n\nBy:\n\n/s/ Gene Mack\n\nName:\n\nGene Mack\n\nTitle:\n\nChief Executive Officer\n\n​\n\n​\n\n​"}